Generally, from memory, buy back ins are generally steep, 15 times, but I haven't read anything with these partners.Bg
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025